DUSA PHARMACEUTICALS, INC.

DUSA PHARMACEUTICALS, INC.

March 02, 2005 08:00 ET

DUSA Pharmaceuticals, Inc. to Host 2004 Corporate Highlights and Financial Results Conference Call


NEWS RELEASE TRANSMITTED BY CCNMatthews

FOR: DUSA PHARMACEUTICALS, INC.

NASDAQ SYMBOL: DUSA

MARCH 2, 2005 - 08:00 ET

Dusa Pharmaceuticals, Inc. to Host 2004 Corporate
Highlights and Financial Results Conference Call

WILMINGTON, MASSACHUSETTS--(CCNMatthews - March 2, 2005) - DUSA
Pharmaceuticals, Inc. (NASDAQ NMS:DUSA) announces that its year end
corporate highlights and financial results press release will be issued
on Monday, March 14, 2005, to be followed by a conference call at 8:45
a.m.



Monday, March 14 - 8:45 a.m. Eastern
If calling from the US or Canada use the following toll-free number:
800.936.4602
Password - DUSA

For International callers use
507.726.3418
Password - DUSA

You will also be able to listen to a replay of the conference call
using the following numbers:
North American callers 800.334.2128
International callers 580.431.2986


The call will be accessible on our web site after the call at
www.dusapharma.com.

DUSA Pharmaceuticals, Inc. is a biopharmaceutical company engaged
primarily in the development of Levulan® Photodynamic Therapy (PDT)
and Photodetection (PD) for multiple medical conditions, with its
primary focus in dermatology. PDT and PD utilize light-activated
compounds to induce a therapeutic or detection effect. DUSA maintains
offices in Wilmington, MA, Valhalla, NY and Toronto, Ontario.

-30-

Contact Information

  • FOR FURTHER INFORMATION PLEASE CONTACT:
    DUSA Pharmaceuticals, Inc.
    Shari Lovell
    Director, Shareholder Services
    (416) 363-5059
    (416) 363-6602 (FAX)
    www.dusapharma.com